Jeil Pharmaceutical Co Ltd (271980) — Free Cash Flow Generation Index

Latest as of September 2025: 0.73x

Jeil Pharmaceutical Co Ltd (271980) has a Free Cash Flow Generation Index of 0.73x as of September 2025. Free cash flow of ₩9.68 Billion represents 1% of operating cash flow (₩13.23 Billion). Read 271980 liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

0.73x
Free Cash Flow / Operating CF

Free Cash Flow

₩9.68 Billion
KRW

Operating Cash Flow

₩13.23 Billion
KRW

Capital Expenditures

₩3.55 Billion
KRW

Jeil Pharmaceutical Co Ltd Free Cash Flow Generation Index (2018–2024)

Historical FCF Generation Index trend for Jeil Pharmaceutical Co Ltd across 4 annual periods. Explore Jeil Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Jeil Pharmaceutical Co Ltd (2018–2024)

Year-by-year Free Cash Flow Generation Index for Jeil Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 271980 company net worth.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 -1.06x ₩-3.40 Billion ₩3.21 Billion ₩6.61 Billion ▼ -247.4%
2021 0.72x ₩13.71 Billion ₩19.10 Billion ₩5.34 Billion ▼ -24.6%
2019 0.95x ₩27.56 Billion ₩28.96 Billion ₩1.09 Billion ▲ +82.9%
2018 0.52x ₩11.17 Billion ₩21.45 Billion ₩10.29 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).